A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria

A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria

BackgroundThe Mayo criteria are the most widely accepted algorithm for predicting the risk of lymph node metastasis in endometrial endometrioid carcinoma (EEC). However, the clinical value of these criteria in high-risk patients is limited and inconclusive.MethodsA total of 240 patients with EEC mee...

Full description

Bibliographic Details
Main Authors:	Wen Lu, Xiaoyue Chen, Jingyi Ni, Zhen Li, Tao Su, Shuangdi Li, Xiaoping Wan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Oncology
Subjects:	endometrial endometrioid carcinoma lymph node dissection Mayo criterion molecular pathological markers serum CA125
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.895834/full

Similar Items

Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients
by: Xi-Lin Yang, et al.
Published: (2021-07-01)

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
by: Sainan Gong, et al.
Published: (2023-07-01)

Validation of an Endometrial Tumor Diameter Model for Risk Assessment in the Absence of Lymph Node Mapping
by: McKayla J. Riggs, et al.
Published: (2020-10-01)

Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma
by: Xingdan Guo, et al.
Published: (2022-12-01)

Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
by: Xiaohang Yang, et al.
Published: (2023-01-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
by: Bozena Dobrzycka, et al.
Published: (2010-04-01)

Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer
by: Yu-Yang Hsiao, et al.
Published: (2022-03-01)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
by: Zhao Liu, et al.
Published: (2021-02-01)

“Cheerios in the lung” as first metastases from endometrial endometrioid adenocarcinoma with adequate response to immunotherapy
by: Chiara De Nardo, et al.
Published: (2023-09-01)

Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study
by: Guangmin Zhang, et al.
Published: (2020-11-01)

Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities
by: Gonçalo Nogueira-Costa, et al.
Published: (2022-01-01)

Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer
by: Yasin Durmus, et al.
Published: (2018-08-01)

Potential Factors Associated with Pelvic Lymph Node Metastasis in Endometrioid Endometrial Carcinoma
by: Prakasit Karavanich, et al.
Published: (2020-04-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
by: Lenka Kalinkova, et al.
Published: (2020-08-01)

Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
by: Fatih Kilic, et al.
Published: (2021-11-01)

Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type
by: Stanojević Zorica, et al.
Published: (2006-01-01)

Impact of middle and lower jugular neck dissection on supraclavicular lymph node metastasis from endometrial carcinoma
by: Kojima Masataka, et al.
Published: (2012-07-01)

Long-term survival of a patient with stage IIIC2 grade 3 endometrioid endometrial carcinoma treated with surgery alone
by: Isao Otsuka, et al.
Published: (2021-11-01)

Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study
by: Aya Ishizaka, et al.
Published: (2022-08-01)

Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study
by: Min Li, et al.
Published: (2019-11-01)

Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
by: Shuang-zheng Jia, et al.
Published: (2018-04-01)

Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
by: Peng Jiang, et al.
Published: (2021-08-01)

Lymphadenectomy and pelvic irradiation in high-risk endometrioid endometrial cancer: a population-based retrospective analysis using the SEER databank
by: AmrA Soliman, et al.
Published: (2021-02-01)

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
by: Mathilde Mairé, et al.
Published: (2022-04-01)

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
by: Basilio Pecorino, et al.
Published: (2022-11-01)

Can Magnetic Resonance Imaging Predict Pathologic Findings for Endometrioid Endometrial Cancer?
by: Elizabeth L. Dickson Michelson, et al.
Published: (2020-04-01)

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
by: Grace Kim, et al.
Published: (2015-08-01)

Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center
by: Mayumi Kobayashi Kato, et al.
Published: (2021-03-01)

Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer
by: Kaiyou Fu, et al.
Published: (2021-04-01)

Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer
by: Jung Hwan Ahn, et al.
Published: (2022-06-01)

Combined deep-learning MRI-based radiomic models for preoperative risk classification of endometrial endometrioid adenocarcinoma
by: Jin Yang, et al.
Published: (2023-10-01)

Atypical Macropinocytosis Contributes to Malignant Progression: A Review of Recent Evidence in Endometrioid Endometrial Cancer Cells
by: Takayuki Kohno, et al.
Published: (2022-10-01)

Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice
by: Danilo D. Obradović, et al.
Published: (2022-09-01)

Systematic Lymph Node Dissection May Be Abolished in Patients With Apparent Early-Stage Low-Grade Mucinous and Endometrioid Epithelial Ovarian Cancer
by: Jiayu Chen, et al.
Published: (2021-09-01)

Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing
by: Yao Wang, et al.
Published: (2019-03-01)

Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer
by: Michał Czerwiński, et al.
Published: (2021-10-01)

When the endometrioid adenocarcinoma and the endometrial stromal sarcoma meet: A report of an extremely rare case
by: Antonios Koutras, et al.
Published: (2022-06-01)

Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma
by: Antonio Bandala-Jacques, et al.
Published: (2020-10-01)

Peripheral Blood Lymphocyte Subsets as a Risk Predictor of Patients with Endometrioid Endometrial Cancer
by: Su P, et al.
Published: (2022-11-01)